DOCTORS: CANCER IS THE 'GREAT EQUALIZER'

The New York Times, March 27 -- A disease that afflicts the comfortable along with everyone else, cancer casts a large shadow in this presidential campaign, and now in the White House. A new Duke University Medical Center study shows how that differs from heart disease. (AP story also appeared in the Seattle Post-Intelligencer and more than 200 other news outlets.) ... Full story
--Also, Bloomberg News: White House Spokesman Snow Has Recurrence of Cancer (Dr. Bryan Clary, chief of liver surgery at Duke) ... Full story

DUKE RESEARCHER TESTS OPTICAL BIOPSY PROCEDURE

(Raleigh) NBC 17 News, March 27 -- Researchers are about to test a new light-based probe built at Duke's Pratt School of Engineering that makes it easier to spot cancer in its incipient stages. ... Full story
--Also, UPI: Light-Based Probe Detects Earliest Cancers ... Full story

PROSTATE CANCER MISDIAGNOSED IN SOME MEN

Sydney Morning Herald, March 28 -- Overweight men are far more likely to get misleading results to prostate cancer tests that compromise their treatment, new Duke-led research has revealed. ... Full story

OP-ED: WHEN THE FRAUD IS AGAINST US ALL

(Raleigh) News & Observer, March 28 -- Duke law professor Paul D. Carrington says it's time for North Carolina to join other states in rewarding private citizens who blow the whistle on fraud. ... Full story

ON COLLEGE CAMPUSES, A CROP OF GALLERIES

The New York Times, March 28 -- When the museum becomes the Big Building on Campus. The Nasher Museum of Art at Duke tops a list of new college galleries. ... Full story

DEAL IN A DURHAM DELI MAY LEAD TO BLOOD THINNER

News & Observer, March 28 -- A Duke spin-off firm announced Tuesday that it had secured the cash to further develop a blood thinner that promises to make cardiovascular surgery safer. ... Full story

WITNESSES DIFFER OVER BIOTECH SAVINGS FROM WAXMAN BILL

Congressional Quarterly, March 26 -- Duke economics professor Henry Grabowski offered testimony before Congress this week that could point to incentives for the development of original biotech drugs. ... Full story

CAMPUS CULTURE AT DUKE

North Carolina Public Radio's "The State of Things," March 27 -- Bob Thompson, the dean of Arts & Sciences, Trinity College at Duke and the chair of the Campus Culture Initiative, was among the guests discussing Duke's coexisting cultures of academic and athletic achievement. ... Full story
--Also, Baltimore Sun: Optimism Creeps In for Duke Parents ... Full story
Newsday: Accused Duke Lacrosse Player Lands at Chaminade ... Full story
Duke News: Duke and Men's Lacrosse (special website with background information) ... Full story

COSTLY HEART TREATMENT IN DOUBT

News & Observer, March 27 -- Dr. Mitch Krucoff, a Duke University Medical Center cardiologist, discusses new research on the use of stents for treating heart patients. (See second page.) ... Full story

IS EARNING AN EXECUTIVE M.B.A. PAST 50 WORTH IT?

Wall Street Journal, March 27 -- Kathie Amato, assistant dean for executive M.B.A. programs at Duke, says an executive M.B.A. degree still has value for people in the post-50 generation. (Link for subscribers; e-mailed upon request to dukenews@duke.edu.) ... Full story for subscribers

EX-COMFORT WOMAN RALLIES SUPPORT AT U.S. UNIVERSITIES

(South Korea) Yonhap News, March 27 -- A Korean woman forced into sexual slavery by Japan during World War II visited Duke on Monday, rallying support for an American congressional resolution holding Japan accountable. ... Full story

OPEN SOURCE SCIENCE

Marketplace, March 28 -- Dr. Bob Cook-Deegan at Duke's Institute for Genome Sciences & Policy discusses a Drexel professor's break with tradition in publishing all of his lab's findings on a wiki. ... Full story

DUKE EMERGENCY ROOM GROWING TO EASE OVERCROWDING

WRAL.com, March 26 -- Duke is expanding and upgrading its emergency department. More beds, new diagnostic equipment and a dedicated pediatric section are part of the work that will begin to open April 2 and should be done by December. ... Full story

ON THE AIR

Duke cognitive scientist Ruth Day will talk about her research on prescription drug ads and how viewers recall the ads' details on Wednesday's edition of "All Things Considered" on NPR. ... Details